While Cognex delivered solid Q2 results, I am now cautious due to the soft demand environment, and the potential delayed impact of tariffs. Growth appears set to strengthen in the coming quarters, but ...
JPMorgan downgraded Cognex (CGNX) to Underweight from Neutral with a price target of $35, down from $45. The firm cites the stock’s “stretched” valuation and cyclical risks facing the company for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback